Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
doi:10.1007/978-981-32-9705-0_9 Stein DJ, Scott KM, de Jonge P, Kessler RC
Its a foundation
Abstract CT214: Preliminary efficacy of telisotuzumab vedotin (Teliso-V) treatment in the 2L/3L setting in MET gene amplified (MET Amp), c-Met protein overexpressing (c-Met OE), non-squamous, non-small cell lung cancer (NSQ NSCLC): retrospective analysis of LUMINOSITY
Safety Protocols and Chemical Stability Safety is the most critical factor when handling Bacteriostatic Water for Injection in any modern medical setting
US$ 25.05
US$ 27.27
US$ 28.39
US$ 25.90
US$ 23.28
US$ 20.09
US$ 28.23
